Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 22 2022 - 8:30AM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development of Intravascular Lithotripsy (IVL) to treat severely
calcified cardiovascular disease, announced today that the company
will be participating in the Piper Sandler 34th Annual Virtual
Healthcare Conference, scheduled to be held from November 29 to
December 1, 2022.
Shockwave management is scheduled for a live fireside chat on
Wednesday, November 30, 2022, at 9:30 a.m. Eastern Time. Interested
parties may access a live and archived webcast of the event on the
"Investors" section of the company’s website at:
https://ir.shockwavemedical.com.
About Shockwave Medical, Inc.
Shockwave is focused on developing and commercializing products
intended to transform the way calcified cardiovascular disease is
treated. Shockwave aims to establish a new standard of care for the
interventional treatment of atherosclerotic cardiovascular disease
through differentiated and proprietary local delivery of sonic
pressure waves for the treatment of calcified plaque, which the
company refers to as Intravascular Lithotripsy (IVL). IVL is a
minimally invasive, easy-to-use and safe way to significantly
improve patient outcomes. To view an animation of the IVL procedure
and for more information, visit www.shockwavemedical.com.
Media Contact:Scott
Shadiow+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterdkaster@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Sep 2023 to Sep 2024